Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,765 | 112,975 | 34,522 | 53,045 | 68,600 |
| Marketable Securities | 232,592 | 225,728 | 240,736 | 248,842 | 251,482 |
| Receivables | 22,809 | 15,828 | 24,790 | 28,043 | 21,380 |
| Other current assets | 23,496 | 27,297 | 20,403 | 23,347 | 22,235 |
| TOTAL | $346,683 | $395,418 | $334,971 | $365,838 | $378,809 |
| Non-Current Assets | |||||
| PPE Net | 123,969 | 127,662 | 132,103 | 135,534 | 138,680 |
| Investments And Advances | 36,943 | 41,807 | 38,871 | 62,639 | 95,302 |
| Other Non-Current Assets | 61,784 | 64,328 | 68,025 | 69,775 | 69,667 |
| TOTAL | $222,696 | $233,797 | $238,999 | $267,948 | $303,649 |
| Total Assets | $569,379 | $629,215 | $573,970 | $633,786 | $682,458 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,362 | 31,356 | 22,786 | 21,859 | 11,639 |
| Accrued Expenses | 42,488 | 33,129 | 49,703 | 45,656 | 50,517 |
| Other current liabilities | 32,100 | 38,615 | 50,567 | 52,750 | 48,963 |
| TOTAL | $98,273 | $110,179 | $130,272 | $127,346 | $117,893 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 21 | 13 | 148 | 442 | 448 |
| Other Non-Current Liabilities | 122,839 | 128,370 | 131,956 | 143,340 | 158,710 |
| TOTAL | $122,839 | $128,370 | $131,956 | $143,340 | $158,710 |
| Total Liabilities | $221,112 | $238,549 | $262,228 | $270,686 | $276,603 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,423 | 49,256 | 44,428 | 43,992 | 43,960 |
| Common Shares | 5 | 5 | 4 | 4 | 4 |
| Retained earnings | -821,366 | -768,377 | -705,047 | -642,158 | -580,290 |
| Other shareholders' equity | -2,266 | -3,229 | -4,429 | -7,413 | -10,098 |
| TOTAL | $348,267 | $390,666 | $311,742 | $363,100 | $405,855 |
| Total Liabilities And Equity | $569,379 | $629,215 | $573,970 | $633,786 | $682,458 |